Literature DB >> 1645656

Multisite contacts involved in coupling of the beta-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein. Structural and functional studies by beta-receptor-site-specific synthetic peptides.

G Münch1, C Dees, M Hekman, D Palm.   

Abstract

Synthetic peptides, 12-22 amino acid residues long, comprising the presumed coupling sites of the beta-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein (Gs), were examined for their ability to modulate Gs activation in turkey erythrocyte membranes. Three peptides corresponding to the second cytoplasmic loop, the N-terminal region of the third cytoplasmic loop, and the N-terminal region of the putative fourth cytoplasmic loop, compete synergistically with the hormone-stimulated receptor for Gs activation with median effector concentrations of 15-35 microM, or 3-4 microM for combinations of two peptides. One peptide, corresponding to the C-terminal region of the third cytoplasmic loop, carries the unique ability to activate the Gs-adenylate-cyclase complex independent of the signalling state of the receptor. These observations are consistent with a dynamic model of receptor-mediated G-protein activation in membranes, where domains composed of the second, third and fourth intracellular loop of the receptor bind to and are interactive with the G-protein heterotrimer, resulting in ligand-induced conformational changes of the receptor. In response to hormone binding, the extent or the number of sites involved in interaction with Gs may be readjusted using a fourth site. Modulation of coupling sites may elicit congruent conformational changes within the Gs heterotrimer, with qualitatively different effects on GTP/GDP exchange in the alpha subunit of Gs and downstream effector regulation. This model corroborates and expands a similar model suggested for activated rhodopsin-transducin interaction [König, B., Arendt, A., McDowell, J. H., Kahlert, M., Hargrave, P. A. & Hofmann, K. P. (1989) Proc. Natl Acad. Sci. USA 86, 6878-6882].

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645656     DOI: 10.1111/j.1432-1033.1991.tb16023.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

Review 1.  Structural features of heterotrimeric G-protein-coupled receptors and their modulatory proteins.

Authors:  H LeVine
Journal:  Mol Neurobiol       Date:  1999-04       Impact factor: 5.590

2.  Attenuation of GTPase activity of recombinant G(o) alpha by peptides representing sequence permutations of mastoparan.

Authors:  C Oppi; T Wagner; A Crisari; B Camerini; G P Tocchini Valentini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 3.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

4.  G-Protein binding domains of the angiotensin II AT1A receptors mapped with synthetic peptides selected from the receptor sequence.

Authors:  H Kai; R W Alexander; M Ushio-Fukai; P R Lyons; M Akers; K K Griendling
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

5.  Inhibition of the ethanol-induced potentiation of α1 glycine receptor by a small peptide that interferes with Gβγ binding.

Authors:  Loreto San Martin; Fabian Cerda; Veronica Jimenez; Jorge Fuentealba; Braulio Muñoz; Luis G Aguayo; Leonardo Guzman
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

6.  Interaction of the human prostacyclin receptor with Rab11: characterization of a novel Rab11 binding domain within alpha-helix 8 that is regulated by palmitoylation.

Authors:  Helen M Reid; Eamon P Mulvaney; Elizebeth C Turner; B Therese Kinsella
Journal:  J Biol Chem       Date:  2010-04-15       Impact factor: 5.157

Review 7.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

8.  Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction.

Authors:  A H Gorn; S M Rudolph; M R Flannery; C C Morton; S Weremowicz; T Z Wang; S M Krane; S R Goldring
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

9.  Galpha protein selectivity determinant specified by a viral chemokine receptor-conserved region in the C tail of the human herpesvirus 8 g protein-coupled receptor.

Authors:  Chaoqi Liu; Gordon Sandford; Guo Fei; John Nicholas
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies.

Authors:  C Neveu; F Dulin; B Lefranc; L Galas; C Calbrix; R Bureau; S Rault; J Chuquet; J A Boutin; L Guilhaudis; I Ségalas-Milazzo; D Vaudry; H Vaudry; J Sopkova-de Oliveira Santos; J Leprince
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.